Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Scientific Reports|March 1, 2016
Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Soon-Ee Cheah, Matthew D Johnson, et al.
Antiviral Therapy|January 6, 2016
Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapyJulie B Dumond, Owen Francis, Mackenzie Cottrell, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic modelZakuan Z Deris, Heidi H Yu, Kathryn Davis, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2016
High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumanniiJustin R Lenhard, Jürgen B Bulitta, Terry D Connell, et al.
Clinical and Translational Science|January 25, 2019
Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive ImpairmentNithya Srinivas, Sarah Beth Joseph, Kevin Robertson, et al.
Pharmacotherapy|February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Current Biology : CB|September 2, 2023
Global Brassicaceae phylogeny based on filtering of 1,000-gene datasetKasper P Hendriks, Christiane Kiefer, Ihsan A Al-Shehbaz, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Scientific Reports|March 1, 2016
Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Soon-Ee Cheah, Matthew D Johnson, et al.
Antiviral Therapy|January 6, 2016
Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapyJulie B Dumond, Owen Francis, Mackenzie Cottrell, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic modelZakuan Z Deris, Heidi H Yu, Kathryn Davis, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2016
High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumanniiJustin R Lenhard, Jürgen B Bulitta, Terry D Connell, et al.
Clinical and Translational Science|January 25, 2019
Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive ImpairmentNithya Srinivas, Sarah Beth Joseph, Kevin Robertson, et al.
Pharmacotherapy|February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Current Biology : CB|September 2, 2023
Global Brassicaceae phylogeny based on filtering of 1,000-gene datasetKasper P Hendriks, Christiane Kiefer, Ihsan A Al-Shehbaz, et al.
Pageof 18